Teva's long haul to a turnaround of its business ... drug were both able to delay the risk of relapse versus placebo, by 80% and 63%, respectively. Shares in MedinCell fell 29% on the Euronext ...

TEL AVIV, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will conduct a conference call and live webcast at 8 am E.T ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Found the MG ZS of your dreams? Now you want to know all about it! With the help of Parkers, you can find out all of the key specs about the MG ZS from fuel efficiency in MPG and top speed in MPH, to ...